Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (171-180 of 471) with videos related to

Pageof 48
Sort By:
JACC. Cardiovascular Interventions|January 15, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsDean J Kereiakes, Krishnankutty Sudhir, James B Hermiller, et al.
The American Journal of Cardiology|August 26, 2011
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)Kenji Goto, Eugenia Nikolsky, Alexandra J Lansky, et al.
The American Journal of Cardiology|April 3, 2012
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three yearsAlexandra J Lansky, Somjot S Brar, Manejeh Yaqub, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled TrialsYousif Ahmad, James P Howard, Henry Seligman, et al.
The American Journal of Cardiology|December 17, 2003
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai, Alexandra J Lansky, Gary S Mintz, et al.
JACC. Cardiovascular Imaging|July 16, 2013
Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT studyTomotaka Dohi, Gary S Mintz, John A McPherson, et al.
Open Heart|October 1, 2024
Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysisNatalija Odanović, Alexandra N Schwann, Zhiyuan Zhang, et al.
The American Journal of Cardiology|January 25, 2011
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial)Vivian G Ng, Alexandra J Lansky, James B Hermiller, et al.
The American Journal of Cardiology|August 14, 2003
Usefulness of a cobalt chromium coronary stent alloyDean J Kereiakes, David A Cox, James B Hermiller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 28, 2013
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)Dariusz Dudek, Roxana Mehran, Artur Dziewierz, et al.
Pageof 48

Showing results (171-180 of 471) with videos related to

Sort By:
Pageof 48
JACC. Cardiovascular Interventions|January 15, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsDean J Kereiakes, Krishnankutty Sudhir, James B Hermiller, et al.
The American Journal of Cardiology|August 26, 2011
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)Kenji Goto, Eugenia Nikolsky, Alexandra J Lansky, et al.
The American Journal of Cardiology|April 3, 2012
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three yearsAlexandra J Lansky, Somjot S Brar, Manejeh Yaqub, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled TrialsYousif Ahmad, James P Howard, Henry Seligman, et al.
The American Journal of Cardiology|December 17, 2003
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai, Alexandra J Lansky, Gary S Mintz, et al.
JACC. Cardiovascular Imaging|July 16, 2013
Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT studyTomotaka Dohi, Gary S Mintz, John A McPherson, et al.
Open Heart|October 1, 2024
Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysisNatalija Odanović, Alexandra N Schwann, Zhiyuan Zhang, et al.
The American Journal of Cardiology|January 25, 2011
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial)Vivian G Ng, Alexandra J Lansky, James B Hermiller, et al.
The American Journal of Cardiology|August 14, 2003
Usefulness of a cobalt chromium coronary stent alloyDean J Kereiakes, David A Cox, James B Hermiller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 28, 2013
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)Dariusz Dudek, Roxana Mehran, Artur Dziewierz, et al.
Pageof 48